TAVR for AR: next steps and future challenges
We Recommend
Disclosures
Within the last 24 months, I have had financial relationship(s) with the ineligible company or companies listed below:
- Consultant Fee/Honoraria/Speaker's Bureau - Abiomed; Abbott Vascular; Medtronic; NuPulse; Teleflex; Terumo Medical Corporation
- Grant Support/Research Contract - Boston Scientific Corporation
- CMO - JenaValve